Explore antibody engineering techniques like phage display, humanization, and computational design, enabling the development of safer and more effective therapeutic antibodies.

Learn how scientists identify antigens for therapeutic antibodies using genomics, bioinformatics, and functional studies, ensuring disease relevance and drugability.

Discover the evolution, advantages, and diagnostic applications of single-chain variable fragments (scFvs) in antibody research. Learn about scFv production systems.

Antibody combination therapies involve the use of two or more antibodies together as a treatment strategy to enhance the therapeutic effect against diseases, such as cancer or infectious diseases. This approach aims to target different epitopes or antigens simultaneously, increasing the efficacy of the treatment by overcoming resistance mechanisms, reducing the likelihood of disease escape, and providing a broader range of action.

Multiple myeloma (MM) is a cancer of plasma cells in the bone marrow, which can cause bone damage, anemia, kidney dysfunction, and weakened immunity. Despite being incurable, advances in antibody therapies have shown significant progress in the management of the disease, highlighting the ongoing efforts in the development of more effective treatments.

Learn about VHH antibodies, their history, applications in diagnostics and therapeutics, and their role in cutting-edge diagnostics like ELISA and biosensors.

Entering into the new year, the popularity of antibody-drug conjugates (ADCs) in the biopharma industry shows no signs of slowing down. In 2023, there were a record number of licensing partnerships in the ADC space, particularly Merck’s $22 billion deal with Daiichi Sankyo, Inc.

Discover Biointron's expertise in producing bispecific antibodies using advanced methods like knobs-in-holes, Ig-scFv fusion, & Diabody-Fc fusion for innovative therapies.

Discover how combination antibody therapies boost treatment efficacy against diseases like cancer & infections. Explore Biointron’s synergistic antibody solutions today!

Discover how monoclonal antibodies combat AMR, targeting bacterial toxins and proteins with innovative designs like nanocages, advancing therapies against resistant pathogens.

Explore cell signaling pathways, their role in immune responses & therapeutic antibody development. Learn how Biointron supports antibody discovery—contact us today!

Discover how allotypes in immunology impact monoclonal antibody therapeutics. Learn how Biointron supports antibody discovery & optimization—contact us today!

Explore the benefits and limitations of monoclonal antibodies, from high specificity and diverse applications to production costs and therapeutic challenges.

Explore the top 10 antibody drugs approved by the FDA in 2023, including Humira, Keytruda & Rituxan. Learn how Biointron supports antibody drug development.

Enhance antibody-based cancer treatments with advanced drug delivery systems. Discover innovative strategies for improved efficacy, reduced toxicity, & patient convenience.